(Q39587518)

English

Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)

scientific article published on January 1, 1979

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) (English)

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

author name string

A. Santoro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A93984

17 April 2022

G. Bonadonna

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A93984

17 April 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=93984

17 April 2022

publication date

1 January 1979

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00254081.pdf

Portable Document Format

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

http://link.springer.com/article/10.1007/BF00254081/fulltext.html

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

http://link.springer.com/content/pdf/10.1007/BF00254081

1 reference

10.1007/BF00254081

https://api.crossref.org/works/10.1007/BF00254081

17 April 2022

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

101-105

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy for advanced resistant Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent trends in the medical treatment of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Combination Chemotherapy for Resistant Hodgkin Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/93984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00254081

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

release_xmawqgd6kjb2jm56s2hoyrf6ea

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39587518&oldid=2203001386"